RxDoctor Payments Data

Peguy Saad, MD

Infectious Disease · Chicago, ILNPI 1417192345

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 10th percentile of 368 infectious disease providers in Illinois.

See all infectious disease providers in Illinois

Medicare billing

Part B allowed, 2024
$684,754
Medicare patients
347
Services billed
25,268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErtapenemErtapenem Sodium16$14,524
Fosfomycin Tromethamine32$8,838
Daptomycin11$7,131
Cefepime Hcl18$2,561
Meropenem16$1,507
CeftriaxoneCeftriaxone Sodium15$455

Paid to pharmacies, not to this prescriber.

Other infectious disease in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →